[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":72286000.0,"MarketableSecuritiesCurrent_0_Q3_USD":228571000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":405479000.0,"MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_3_Q3_USD":221000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":6320000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-158043000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":78364000.0,"NetIncomeLoss_1_Q3_USD":21562000.0,"NetIncomeLoss_3_Q3_USD":50982000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":21562000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":50982000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3644000.0,"NonoperatingIncomeExpense_3_Q3_USD":-8807000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OperatingIncomeLoss_1_Q3_USD":32604000.0,"OperatingIncomeLoss_3_Q3_USD":79931000.0,"LiabilitiesCurrent_0_Q3_USD":234711000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5904000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1555040000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":845000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":13351000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":1147030.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":1248020.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":346619000.0,"InterestExpense_1_Q3_USD":5925000.0,"InterestExpense_3_Q3_USD":17489000.0,"InterestExpenseDebt_1_Q3_USD":5033000.0,"InterestExpenseDebt_3_Q3_USD":14593000.0,"InterestExpenseOther_1_Q3_USD":892000.0,"InterestExpenseOther_3_Q3_USD":2896000.0,"InterestPaidNet_3_Q3_USD":1887000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":12535000.0,"InventoryNet_0_Q3_USD":60155000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q3_USD":9710000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":37910000.0,"Liabilities_0_Q3_USD":744572000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":37261000.0,"OperatingLeasePayments_3_Q3_USD":7613000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":30108000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q3_USD":27575000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":19654000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":69389000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":15000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":377480000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":148464000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":420725000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":72032000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":203024000.0,"ShareBasedCompensation_3_Q3_USD":13874000.0,"StockholdersEquity_0_Q3_USD":810468000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":524000.0,"UnrealizedGainLossOnDerivatives_3_Q3_USD":7650000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":54334794.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":54301461.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q3_USD":16471000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q3_USD":11104000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":152546000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":5520000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":8415000.0,"OtherAssetsNoncurrent_0_Q3_USD":40133000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-1224000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-4766000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-1224000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-4766000.0,"OtherLiabilitiesCurrent_0_Q3_USD":6807000.0,"IncreaseDecreaseInInventories_3_Q3_USD":9331000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":18186000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":2281000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":8682000.0,"OtherSundryLiabilitiesNoncurrent_0_Q3_USD":10047000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":950000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":307634000.0,"PaymentsToAcquireOtherInvestments_3_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":30692000.0,"OtherNoncashIncomeExpense_3_Q3_USD":22000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":53187764.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-7352000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":20142000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":289000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":628461000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":228571000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":634050000.0,"BusinessCombinationConsiderationTransferred1_3_Q3_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":80000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-7650000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":69050000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":23570000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":45480000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":215281000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":215281000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-73359000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":80.9063,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":5878000.0,"CommonStockSharesAuthorized_0_Q3_shares":130000000.0,"AssetsCurrent_0_Q3_USD":668375000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":17964000.0,"AccountsPayableCurrent_0_Q3_USD":9125000.0,"AccountsReceivableNetCurrent_0_Q3_USD":133676000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":72286000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":7453000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":12781000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":4209000.0,"AdditionalPaidInCapital_0_Q3_USD":428726000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4027000.0,"AdvertisingExpense_1_Q3_USD":22600000.0,"AdvertisingExpense_3_Q3_USD":59700000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4027000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13874000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q3_USD":4400000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":13037000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":6009000.0,"Assets_0_Q3_USD":1555040000.0,"CommonStockSharesIssued_0_Q3_shares":53180643.0,"CommonStockSharesOutstanding_0_Q3_shares":52868482.0,"CommonStockValue_0_Q3_USD":53000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q3_USD":100000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3_Q3_USD":-7650000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":69050000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":0.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":0.0,"FinanceLeasePrincipalPayments_3_Q3_USD":0.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":0.0,"FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":52201000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":398820000.0,"Goodwill_0_Q3_USD":77963000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":28960000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":71124000.0,"IncomeTaxesPaidNet_3_Q3_USD":25111000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":7398000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":13426000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.283,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.255,"EarningsPerShareDiluted_3_Q3_USD":0.94,"ComprehensiveIncomeNetOfTax_1_Q3_USD":20338000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":46216000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":374788000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":18085000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":58067000.0,"CostsAndExpenses_1_Q3_USD":115860000.0,"CostsAndExpenses_3_Q3_USD":340794000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-15726000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_3_Q3_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":34146000.0,"DepreciationAndAmortization_1_Q3_USD":600000.0,"DepreciationAndAmortization_3_Q3_USD":1900000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":19888000.0,"EarningsPerShareBasic_1_Q3_USD":0.41,"EarningsPerShareBasic_3_Q3_USD":0.96,"EarningsPerShareDiluted_1_Q3_USD":0.4,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-479000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":53053441.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]